EQUITY ALERT: Rosen Law Firm Announces Investigation of Durata Therapeutics, Inc. Concerning its Proposed Sale to Actavis plc...
October 06 2014 - 11:35AM
Business Wire
The Rosen Law Firm, P.A. announces that it is investigating the
Board of Directors of Durata Therapeutics, Inc. (NASDAQ:DRTX) for
possible breaches of fiduciary duty and other violations of law by
failing to adequately shop Durata to maximize shareholder value
before agreeing to be acquired by Actavis plc (NYSE:ACT).
If you would like to join the action, go to
http://rosenlegal.com/cases-387.html or contact Phillip Kim or
Kevin Chan, toll-free at 866-767-3653, or via e-mail at
pkim@rosenlegal.com or kchan@rosenlegal.com. There is no cost or
obligation to you.
Under the terms of the proposed transaction, shareholders will
receive $23.00 in cash and the right to receive an additional
payment of up to $5.00 per share, if certain goals are reached, for
each share of Durata they own. The proposed transaction is valued
at approximately $675 million. The investigation relates to whether
the proposal for $23.00 in cash and the right to receive an
additional payment of up to $5.00 per share is fair to public
shareholders and whether Durata’s Board breached its fiduciary
duties in connection with the proposed sale.
If you currently own shares of Durata and wish to obtain
additional information, please visit the website at
http://rosenlegal.com/cases-387.html. You may also contact Phillip
Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653
or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
The Rosen Law Firm P.A.Phillip Kim, Esq.Kevin Chan, Esq.Laurence
Rosen, Esq.275 Madison Avenue 34th FloorNew York, New York
10016Tel: (212) 686-1060Toll Free: 1-866-767-3653Fax: (212)
202-3827pkim@rosenlegal.comkchan@rosenlegal.comlrosen@rosenlegal.comwww.rosenlegal.com
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Jul 2023 to Jul 2024